Evidence map›Paper›PMID 41767572›Full record

ArticleFrontiers in microbiology2026

Probiotic-based therapeutics for a One Health future: redefining antibiotic dependency to combat antimicrobial resistance.

Veilumuthu Pattapulavar, Sanjai Kumar S, Sathiyabama Ramanujam, Saranyadevi Subburaj, Godwin Christopher John

Abstract read
In one paragraph

Article in Frontiers in microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Veilumuthu PattapulavarDepartment of Biomedical Sciences, School of Biosciences and Technology, Vellore Institute of Technology, Vellore, India.
Sanjai Kumar SDepartment of Biomedical Sciences, School of Biosciences and Technology, Vellore Institute of Technology, Vellore, India.
Sathiyabama RamanujamDepartment of Science and Humanities, Karpagam Academy of Higher Education, Coimbatore, India.
Saranyadevi SubburajDepartment of Biotechnology, Faculty of Engineering (FoE), Karpagam Academy of Higher Education, Coimbatore, India.
Godwin Christopher JohnDepartment of Biomedical Sciences, School of Biosciences and Technology, Vellore Institute of Technology, Vellore, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antimicrobial resistance (AMR) has become a major One Health concern, affecting the interconnected microbial systems shared by humans, animals, and the environment. Decades of antibiotic-driven control have disturbed ecological stability and contributed to the expansion of the global resistome. This Perspective approaches AMR mitigation through an ecological restoration lens, outlining a three-part strategy that brings together probiotic therapeutics, microbiome-focused public awareness, and integrated surveillance. Probiotics are presented as biologically compatible tools that promote microbial stability through competitive niche occupation, immune support, and environmental biodegradation, thereby reducing selective pressures that favor resistance. In parallel, strengthening microbiome literacy can guide behavioral choices that support stewardship and reduce unnecessary antimicrobial use. The proposed One Health Microbiome Intelligence Framework (OH-MIF) adds a data-driven layer by linking genomic, clinical, agricultural, and environmental information through AI-enabled analytics. Together, these components form an adaptable system that shifts AMR management from reactive dependence on antibiotics toward a more resilient, coexistence-based approach. By aligning ecological interventions with education and policy intelligence, this Perspective positions microbial balance as a practical foundation for sustainable AMR control within broader planetary health goals.

Indexed as

AI-driven surveillanceantimicrobial resistance (AMR)ecological therapeuticsmicrobial resiliencemicrobiome literacyOne Health Microbiome Intelligence Framework (OH-MIF)probiotics

Identifiers

PMID41767572
PMCPMC12938677

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.